Hansen Medical (NASDAQ: HNSN) said economic conditions have led to lower than expected Q4 sales. HNSN, a developer of products for robotic catheter-based technologies, closed at $6.26. Thomas Weisel Partners has a $8 price target on HNSN. HNSN February call option implied volatility is at 115, puts are at 133, above its 26-week average of 69, according to Track Data, suggesting larger price movement.
Cardinal Health (NYSE: CAH), a drug wholesaler and medical-equipment supplier, lowered its full-year outlook on January 8 because it sees reduced hospital spending. Smith Barney has a 12-month price target of $39 on CAH. February option implied volatility of 49 is above its 26-week average of 41 according to Track Data, suggesting larger price movement.
Becton Dickinson (NYSE: BDX), a medical technology company, closed at $69.11. Morgan Stanley raised its rating on BDX to Overweight. BDX February option implied volatility of 38 is above its 26-week average of 33, according to Track Data, suggesting larger price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
Nuclear power is on the comeback trail
Apple backs AT&T in continuing spat with Verizon
Closing Bell: The recession is still over, still... do you feel it?
